All In Biotech

Free tool

FAERS Monitor: Promacta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022291 or its brand name (Promacta, Eltrombopag Olamine). Reports on generic versions are filed under their own applications.

Reports

19,469

Serious

11,673

60% of reports

Hospitalization

4,283

Death reported

4,302

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • platelet count decreased3,722
  • death3,223
  • drug ineffective1,482
  • platelet count increased1,069
  • fatigue1,054
  • headache884
  • nausea756
  • diarrhoea738
  • malaise567
  • off label use525
  • product use in unapproved indication513
  • asthenia485
  • dizziness467
  • contusion449
  • pyrexia443

Reports by year received

View as table
YearReports
2009118
2010414
2011674
2012316
2013348
2014513
20151,142
2016707
2017979
20181,126
20191,590
20201,736
20212,198
20222,750
20232,407
20241,235
2025802
2026414

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,690 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
platelet count increasedSignal1,06996.490.792,634
platelet count decreasedSignal3,72239.137.9133,835
contusionSignal4495.14.61,457
deathSignal3,2234.13.97,697
product use in unapproved indicationSignal5132.22.1354
headache8841.51.4163
fatigue1,0541.51.4160
malaise5671.41.365
asthenia4851.41.355
pyrexia4431.41.347
diarrhoea7381.21.234
drug ineffective1,4821.21.260
nausea7561.01.01
dizziness4671.00.90
off label use5250.60.6105

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.